MFW
AKBA icon

Mosaic Family Wealth’s Akebia Therapeutics AKBA Stock Holding History

Mosaic Family Wealth’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-400
Closed -$6K – 667
2017
Q4 		$6K Hold
400
– – ﹤0.01% 571
2017
Q3 		$8K Hold
400
– – ﹤0.01% 593
2017
Q2 		$6K Hold
400
– – ﹤0.01% 542
2017
Q1 		$4K Hold
400
– – ﹤0.01% 604
2016
Q4 		$4K Hold
400
– – ﹤0.01% 576
2016
Q3 		$4K Hold
400
– – ﹤0.01% 599
2016
Q2 		$3K Hold
400
– – ﹤0.01% 652
2016
Q1 		$3K Buy
+400
New +$3.24K ﹤0.01% 644

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Mosaic Family Wealth's AKBA Position: Q1 2018 in Review

Mosaic Family Wealth sold out of Akebia Therapeutics (AKBA) in Q1 2018, closing a stake of 400 shares — an estimated $6K sold.

Mosaic Family Wealth first reported a position in AKBA in Q1 2016 and held it in 8 quarters. The position peaked at $8K in Q3 2017. 153 funds tracked by Wall St. Rank hold AKBA as of Q1 2018.

  • Mosaic Family Wealth reported no remaining Akebia Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Mosaic Family Wealth sold 400 Akebia Therapeutics shares in Q1 2018, an estimated $6K.
  • Mosaic Family Wealth first reported a position in Akebia Therapeutics in Q1 2016 and held it in 8 quarters.
  • Mosaic Family Wealth's Akebia Therapeutics position peaked at $8K in Q3 2017.
  • 153 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2018.

Based on Mosaic Family Wealth's 13F filing for Q1 2018, filed 15 May 2018.